EPISODE · Jul 5, 2010 · 10 MIN
The Lancet Oncology: July 05, 2010
from Listen to The Lancet Oncology · host The Lancet
Roy Herbst discusses the Zodiac trial, a phase 3 study assessing the efficacy of vandetanib for treating advanced non-small-cell lung cancer.
Embed this episode
NOW PLAYING
The Lancet Oncology: July 05, 2010
0:00
10:07
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Listen to The Lancet Oncology?
This episode is 10 minutes long.
When was this Listen to The Lancet Oncology episode published?
This episode was published on July 5, 2010.
Can I download this Listen to The Lancet Oncology episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!